trial

The Effectiveness of Assertive Community Treatment on Schizophrenic Patients

NCTId NCT04511663
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 198 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2019-09-18
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
198 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2017-07-01
Primary completion
2019-09-18
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Assertive community treatmentBasic public health services.

Sponsors

Shanghai Mental Health CenterLead Sponsor

Investigators

1
Jun CaiStudy Director

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
198
Phase
NA
Primary Completion Date
2019-09-18
Status
COMPLETED
relationships
The graph out of here
drug
Assertive community treatment
drug
Basic public health services.
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jun Cai
person